CXCR4 and Miyoshi myopathy: Because we recently reviewed several of these novel tracers [22], and because data published about MM therapeutic assessment concern only 68Ga-Pentixafor ligand targeting CXCR4 up until now, here we restrict our review to the potential interest of this CXCR4 tracer for therapeutic assessment and MRD detection in MM.